A new treatment option has become available for severe epilepsy: fenfluramine, which is now available on the NHS for children and adults living with Lennox–Gastaut syndrome (LGS).
Diabetes UK and JDRF have announced their continued commitment to revolutionising Type 1 diabetes treatment, by awarding £490,000 to fund the next generation of immunotherapy research.
Department of Health and Social Care announces improvements to the Accelerated Access Collaborative (AAC) that will put the most promising medicines, diagnostic tools and digital services through clinical development and regulatory processes faster.
Dr. Lynne Green speaks to Nishat from Open Access Government about NHS eating disorder treatment, what to do if someone is suffering, and how social media has changed the landscape.
Laura Kirschbacher, Corporate Communications Manager at Pfalzklinikum AdöR talks about ward-equivalent treatment (WeT), a special kind of hometreatment, where a multi-professional team visits the patients at home: She accompanied WeT social worker Linda Seez to find out more.
Jérôme Galon, Director of Research and Head of the Laboratory of Integrative Cancer Immunology at INSERM, explains Immunoscore®, an in vitro diagnostic test that predicts the risk of relapse in colon cancer patients.
From the stories appearing about CBD and its near miraculous effects, to the pharmaceutical companies rushing to catch up, it seems everyone is taking about cannabidiol.
THz and millimetre wave frequency techniques, combined with thin film measurement methods, provide early detection of corneal edema associated with disease in the view of Zachary Taylor, Assistant Professor at Aalto University.
Jane Kinghorn, Director of the Translational Research Office at UCL, discusses the importance of research and partnership in improving the health and wealth of the UK.
Taking advantage of data and trustworthy collaboration is the way to go when it comes to a life- and disease course approach to health protection and chronic care, argues Prof Dr Freimut Schliess, Director of Science & Innovation at Profil GmbH.
DiaChemo is a European project developing a platform technology for point-of-care devices for therapeutic drug monitoring in cancer treatment and beyond, reveals Dr Silke Krol, Head of the Translational Nanotechnology Lab and Coordinator of the DIACHEMO Project.
The UK is set to train many more highly skilled engineers in prosthetics and orthotics following the announcement of a new global centre of excellence based at the University of Salford.
Michael Roth, Research Group Leader at University Hospital Basel asks if disturbed cell-cell interaction causes asthma and provides a fascinating response.
The Department of Health in Northern Ireland pledge to replace the bowel cancer screening test in the country with the new, more accurate Faecal Immunochemical Test (FIT) from early 2020.
Ramya Sriram, manager at Kolabtree, explains why many patients in the UK still cannot access medical cannabis and how scientific communication and further research can lead to change.
